Poly ICLC is an immunostimulant.

It is polyinosinic-polycytidylic acid (poly I:C) mixed with the stabilizers carboxymethylcellulose and polylysine.

[1] It is under trial for use in cancer.

[2] Poly I:C is a ligand for toll like receptor-3, which usually triggers on the structurally similar double-stranded RNA present in some viruses.

This antineoplastic or immunomodulatory drug article is a stub.